FDA aims to sharpen up recall notification process
This article was originally published in Clinica
The FDA is revamping some of its recall procedures to ensure that recall notices are actually seen. Nearly all recalls are left up to the manufacturer but they often do not reach the healthcare professionals who need to know them. As a result the response rate is typically no better than about 5%.